In this study, we provided evidence that DXM combined with ATV can increase the plasma concentrations of ATV and its active metabolites and reduce ATV levels in hepatocytes. The potential mechanism may be the inhibition of the LXRα-OATP1B1 pathway by DXM. Increasing the distribution of ATV in peripheral blood may be beneficial for the treatment of CSDH.